Low density lipoprotein and cardiovascular disease
Pro Research Analysisby 
Searched over 200M research papers
Low-Density Lipoprotein (LDL) and Atherosclerotic Cardiovascular Disease: Causal Relationship
Extensive genetic, epidemiological, and clinical research has established that low-density lipoproteins (LDL) are a direct cause of atherosclerotic cardiovascular disease (ASCVD). Studies show a consistent, dose-dependent relationship between higher LDL cholesterol (LDL-C) levels and increased risk of ASCVD events. This association is observed across genetic studies, large cohort studies, and randomized clinical trials, and the risk increases with both the magnitude and duration of LDL-C exposure. Lowering LDL-C by any effective means reduces ASCVD risk proportionally to the degree and duration of LDL-C reduction, provided there are no harmful side effects from the intervention .
LDL Cholesterol Levels and Cardiovascular Risk in Different Populations
Research in both high-risk and low-risk populations demonstrates that elevated LDL-C is associated with higher rates of cardiovascular disease and mortality. Even among individuals with a low 10-year risk of ASCVD, higher LDL-C and non–HDL-C levels (≥160 mg/dL) are linked to a 50% to 80% increased risk of cardiovascular death over the long term . However, the presence of coronary artery calcification (CAC), a marker of atherosclerosis, modifies this risk. In middle-aged individuals, LDL-C is strongly associated with ASCVD events only in those with evidence of coronary atherosclerosis (CAC>0), but not in those without CAC .
LDL Particle Number, Size, and Subfractions: Predictive Value for Cardiovascular Disease
LDL particles vary in size and density, with small dense LDL (sdLDL) particles being particularly atherogenic. High concentrations of sdLDL are more strongly associated with cardiovascular risk than LDL particle size alone. sdLDL is more prone to modifications such as oxidation, which increases its ability to promote inflammation and atherosclerosis. Measuring sdLDL concentration may provide better risk prediction than total LDL-C, although further research is needed to standardize its clinical use 3468+1 MORE.
Mechanisms: Oxidized LDL and the Role of LOX-1 in Atherosclerosis
Oxidized LDL (oxLDL) plays a crucial role in the development and progression of atherosclerosis. The lectin-like oxidized LDL receptor-1 (LOX-1) is a key driver of this process, promoting endothelial dysfunction, plaque formation, and ultimately leading to events such as myocardial infarction and stroke. LOX-1 is expressed in various cell types involved in atherosclerosis, making it a promising target for future diagnostic and therapeutic strategies .
Related Lipoproteins: Lipoprotein(a) and Residual Cardiovascular Risk
Lipoprotein(a) [Lp(a)] is an LDL-like particle that also contributes to cardiovascular risk through mechanisms such as vascular inflammation and thrombosis. Elevated Lp(a) levels are associated with increased risk of ASCVD and aortic valve stenosis, even after optimizing traditional risk factors and lowering LDL-C. Current therapies have limited effectiveness in lowering Lp(a), but new nucleic acid-based treatments show promise for future risk reduction .
Conclusion
The evidence is clear: LDL, especially in higher concentrations and in more atherogenic forms like sdLDL and Lp(a), is a major cause of atherosclerotic cardiovascular disease. Lowering LDL-C reduces cardiovascular risk, and the impact is greater with longer and more substantial reductions. Understanding the roles of LDL particle number, size, and modifications such as oxidation can further refine risk assessment and guide future therapies.
Sources and full results
Most relevant research papers on this topic